A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part I: exploring theoretical insights and pharmacological advances-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part I: exploring theoretical insights and pharmacological advances

Published:2024-03-03 Issue:3 Volume:21 Page:423-435
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Unnithan Devika¹,Sartaj Ali¹,Iqubal Mohammad Kashif²,Ali Javed¹,Baboota Sanjula¹

Affiliation:

1. Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India

2. Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Texas A&M University, College Station, TX, USA

Funder

Savitribai Jyotirao Phule Fellowship for Single Girl Child

Department of Pharmaceutics, School of Pharmaceutical Education and Research

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2024.2331214

Reference126 articles.

1. Therapeutic nanoplatforms and delivery strategies for neurological disorders

2. The Emerging Evidence of the Parkinson Pandemic

3. Computational medication regimen for Parkinson’s disease using reinforcement learning

4. Parkinson disease

5. Understanding multifactorial architecture of Parkinson’s disease: pathophysiology to management

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP